brinzolamide has been researched along with Disease Models, Animal in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 3 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Briganti, F; Menabuoni, L; Mincione, F; Mincione, G; Scozzafava, A; Supuran, CT | 1 |
| Bacciottini, L; Casini, A; Masini, E; Mincione, F; Scozzafava, A; Scrivanti, C; Starnotti, M; Supuran, CT; Vullo, D | 1 |
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Bhalerao, H; Chandran, S; Koteshwara, KB | 1 |
| Kawamura, A; Kozai, S; Kunikane, E; Kurata, M; Shigemi, W; Shinno, K; Suzuki, G | 1 |
| Hirvonen, J; Ilkka, J; Järvinen, K; Kalesnykas, G; Laaksonen, T; Laru, J; Liu, P; Oksala, O; Peltonen, L; Puranen, J; Rönkkö, S; Tuomela, A | 1 |
| Kim, JH; Lee, DE; Lee, JH; Park, CK; Park, HY | 1 |
| Chen, DF; Chen, H; Cho, KS; Guo, W; Luo, G; Pang, IH; Wang, WH; Yang, Q; Yu, D | 1 |
| Bobeico, V; Nenciu, A; Oprean, C; Paiu, M; Stefan, C; Trifu, A | 1 |
9 other study(ies) available for brinzolamide and Disease Models, Animal
| Article | Year |
|---|---|
Carbonic anhydrase inhibitors: synthesis of water-soluble, aminoacyl/dipeptidyl sulfonamides possessing long-lasting intraocular pressure-lowering properties via the topical route.
Topics: Administration, Topical; Animals; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cell Membrane Permeability; Cornea; Delayed-Action Preparations; Dipeptides; Disease Models, Animal; Glaucoma; Humans; Intraocular Pressure; Isoenzymes; Models, Molecular; Rabbits; Solubility; Sulfonamides; Time Factors | 1999 |
Carbonic anhydrase inhibitors: design of thioureido sulfonamides with potent isozyme II and XII inhibitory properties and intraocular pressure lowering activity in a rabbit model of glaucoma.
Topics: Animals; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Disease Models, Animal; Drug Design; Glaucoma; Intraocular Pressure; Rabbits; Structure-Activity Relationship; Sulfonamides | 2005 |
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Design, optimisation and evaluation of in situ gelling nanoemulsion formulations of brinzolamide.
Topics: Administration, Ophthalmic; Animals; Castor Oil; Delayed-Action Preparations; Disease Models, Animal; Drug Compounding; Emulsions; Glaucoma; Humans; Intraocular Pressure; Nanoparticles; Polysaccharides, Bacterial; Polysorbates; Rabbits; Sulfonamides; Thiazines | 2020 |
Ocular and systemic pharmacokinetics of brimonidine and brinzolamide after topical administration in rabbits: comparison between fixed-combination and single-drug formulations.
Topics: Administration, Topical; Adrenergic alpha-2 Receptor Agonists; Animals; Aqueous Humor; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Chromatography, High Pressure Liquid; Disease Models, Animal; Drug Compounding; Drug Therapy, Combination; Glaucoma; Male; Ophthalmic Solutions; Rabbits; Sulfonamides; Tandem Mass Spectrometry; Thiazines; Vitreous Body | 2021 |
Brinzolamide nanocrystal formulations for ophthalmic delivery: reduction of elevated intraocular pressure in vivo.
Topics: Administration, Ophthalmic; Animals; Calorimetry, Differential Scanning; Carbonic Anhydrase Inhibitors; Cell Line; Cell Survival; Chemistry, Pharmaceutical; Disease Models, Animal; Epithelium, Corneal; Excipients; Glaucoma; Humans; Hypromellose Derivatives; Intraocular Pressure; Male; Microscopy, Electron, Scanning; Nanoparticles; Nanotechnology; Particle Size; Polysorbates; Rats, Wistar; Solubility; Sulfonamides; Surface Properties; Technology, Pharmaceutical; Thiazines; Time Factors | 2014 |
Changes of the Retina and Intrinsic Survival Signals in a Rat Model of Glaucoma following Brinzolamide and Travoprost Treatments.
Topics: Administration, Topical; Animals; Antihypertensive Agents; bcl-X Protein; Blotting, Western; Carbonic Anhydrase Inhibitors; Cell Survival; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Glial Fibrillary Acidic Protein; In Situ Nick-End Labeling; Intraocular Pressure; Male; Ocular Hypertension; Ophthalmic Solutions; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Sprague-Dawley; Retina; Retinal Ganglion Cells; Signal Transduction; Sulfonamides; Thiazines; Travoprost | 2011 |
Microbead-induced ocular hypertensive mouse model for screening and testing of aqueous production suppressants for glaucoma.
Topics: Animals; Antihypertensive Agents; Aqueous Humor; Brimonidine Tartrate; Carbonic Anhydrase Inhibitors; Disease Models, Animal; Drug Evaluation, Preclinical; Feasibility Studies; Intraocular Pressure; Latanoprost; Mice; Mice, Inbred C57BL; Microspheres; Muscarinic Agonists; Ocular Hypertension; Optic Nerve; Pilocarpine; Prostaglandins F, Synthetic; Quinoxalines; Retinal Ganglion Cells; Sulfonamides; Thiazines; Timolol; Tomography, Optical Coherence | 2012 |
[The role of Brinzolamide 1% ophtalmic suspension in corneal edema].
Topics: Administration, Topical; Animals; Carbonic Anhydrase Inhibitors; Computer Graphics; Corneal Edema; Disease Models, Animal; Drug Evaluation, Preclinical; Placebo Effect; Rabbits; Sulfonamides; Thiazines; Treatment Outcome | 2002 |